AbbVie/Enanta Post Stellar Phase 3 Data But No One Is Cheering
Apr 21, 2017Jeremy Parkinson0
AbbVie Inc. (NYSE:ABBV) and its partner Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) received exceedingly good news about new Phase III data on their hep C combo for glecaprevir/pibrentasvir. BUT since these drugs first went into combo clinical trials, the market has peaked and begun a painful retreat as the top players scramble to stay competitive. Written by […]
Broken Employment
Apr 21, 2017Jeremy Parkinson0
For the third consecutive month real average weekly earnings fell year-over-year. In March, at least, with the CPI starting its downward leg the decline was by the smallest amount; essentially flat but fractionally less than zero. It was the first time real wages have fallen three in a row since early 2012. The six-month average […]
EUR/USD: Trading ‘Frexit’ Risks – BofAML
Apr 21, 2017Jeremy Parkinson0
The French elections have just become more complicated with the shooting in Paris. What are the risks of this event on EUR/USD? Here is an opinion from Bank of America Merrill Lynch: Here is their view, courtesy of eFXnews: Bank of America Merrill Lynch FX Strategy Research notes that heading into the French elections, markets are still underpricing the risk, […]
Crude Oil Prices Extend Drop As OPEC Struggles With Reducing Glut
Apr 21, 2017Jeremy Parkinson0
Commodities made little headway over the past trading day. Crude oil prices continued to fall but momentum noticeably slowed from the previous day’s breakneck selloff. Whispers of preliminary agreement on extending the OPEC-led supply cut deal failed to impress after Saudi Arabia Energy Minister Khalid Al-Falih said the scheme failed to reach its inventory reduction goal, at least so far. […]
April 21st – Daily Trading Opportunities
Apr 21, 2017Jeremy Parkinson0
The session on Thursday features Manufacturing PMI numbers coming from both the European Union and the German economies, so it seems very likely that the markets will be tilted towards earlier trading than anything else. DAX German markets had a slightly positive session on Wednesday, but still look a bit weak. We need to hold […]
Recent Buy – CVS Health Corp (CVS)
Apr 20, 2017Jeremy Parkinson0
This purchase shouldn’t surprise too many of you. Often times, Lanny will find a great dividend growth stock on a discount and sell me on the fact that the company is a buy. Well, this time was definitely one of those instances and I followed his lead in purchasing shares in this dividend growth stock. […]
Bouncing Off Support
Apr 20, 2017Jeremy Parkinson0
“I realized that becoming a master of karate was not about learning 4,000 moves but about doing just a handful of moves 4,000 times.” — Chet Holmes Stocks held support areas and are moving up. We’re not breaking out, just consolidating in most cases, so more time is needed but things are holding and shaping up […]
Buffalo Bill’s Wild West Show: Winners And Losers
Apr 20, 2017Jeremy Parkinson0
Continuing with the Wild West theme, “Buffalo Bill” Cody staged the period with “border dramas.” Buffalo Bill’s fame as a westerner gave his shows star appeal and an aura of authenticity. The market has had its own border drama this week. The sentiment has fluctuated between fear that the talk of strengthening fundamentals are just […]
E*Trade Financial Corp. Q1 Earnings Top Expectations As Revenue Jumps 17%
Apr 20, 2017Jeremy Parkinson0
E*Trade Financial Corp (ETFC) late Thursday posted better than expected first quarter earnings results, as it successfully navigated through an increasingly competitive brokerage landscape.
Chevron Sell-Off Continues With $1.1B Exit Of Canada Fuel Assets
Apr 20, 2017Jeremy Parkinson0
by Adam Putz, PitchBook Parkland Fuel (TSX: PKI)(PKIUF) has agreed to acquire Chevron Canada R&M, which operates the Canadian integrated downstream fuel business of oil & gas giant Chevron (NYSE: CVX). The C$1.46 billion (~$1.1 billion) deal comprises: 129 Chevron service stations principally in Vancouver, bringing Parkland’s total of Chevron-branded sites in British Columbia to […]